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Abstract: We developed a novel method to prepare nanocapsules. A solute often crystallizes 
when its solubility alters from one solvent to another, and its firstborn crystals are used as templates 
to prepare nanocapsules for the first time, which is called firstborn microcrystallization method. 
By using this method, the maximum diameter of the nanocapsules including artesunate is about 
76 nm, and wrapping state is well. One important advantage of our method is that the preparation 
of the nanocapsules operates easily and is a one-time process with no other cumbersome processes 
necessary, therefore avoiding secondary pollution. The proposed method provides a new route to 
prepare monodisperse nanocapsules to increase bioavailability of hydrophobic solutes.
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Introduction
Drug delivery system (DDS) has been a hot issue in the pharmaceutical field for a long 
time. To realize this system, some strategies have been explored.1–5 One main strat-
egy has been using submicrometer or nanometer-sized capsules as carriers of a drug. 
Their characteristics are larger inner volume and much higher interfacial area per unit 
mass of macro- or nanoparticles, which help carry more drug and having much greater 
exchange rates.6 Furthermore, microencapsulation of drugs can reduce its toxic side 
effects and improve its stability. Especially for intravenous injection, the nanocapsules 
with drugs can pass the smallest capillaries in the body without blockage. Therefore the 
preparation of the nanocapsules is of both scientific and technological interest.
Artesunate, a water-soluble derivative of artemisinin, which is a traditional Chinese 
medicine, is a product of artemisinin modified with hydroxyl groups. Its solubility in 
water is slightly better than that of artemisinin while both do not dissolve in water. It 
is a white powder, odorless, almost tasteless, and can dissolve easily in ethanol or ethyl 
  acetate. It can play major roles in the asexual body of plasmodium in the   erythrocytic 
stage and can also be used to treat malaria, particularly in multidrug-resistant   falciparum 
malaria, antiprogesterone, antifibrosis, antischistosomiasis, antitoxoplasma, antiar-
rhythmia, and tumor cell toxicity, and so on. Its structure is shown in Figure 1. In certain 
applications, however, a nanocapsule including artesunate is preferred to   investigate 
its behavior, dynamics, and bioavailability. Unfortunately, until very recently, little 
attention has been paid to microencapsulation of artesunate.
Preparation of microcapsules have different methods such as nanoprecipitation,7,8 
emulsion–diffusion,9 double emulsification,10 emulsion–coacervation,11   polymer-coating,12 
layer-by-layer,13 and self-templating.14 While the range of size generally obtained is 100–
500 nm15 which is not nanoscale in the strict sense of the term, and the preparation is a multistep International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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process including removing emulsifier or   templates,   loading drug, 
which means secondary pollution and a long cycle.16 Up till now, 
research on the nanocapsules is still continuing.
In this work, we report on a novel method, called firstborn 
microcrystallization method, to prepare drug-containing 
nanocapsules. Because there is different solubility of drug in 
different solvents, its firstborn crystals, which arise when the 
saturated drug in one solvent with larger solubility adds to 
other with smaller solubility, are used as templates to prepare 
  nanocapsules. To explore preparation conditions, effects of some 
factors such as organic solvent, formaldehyde dosage, artesunate 
dissolving and curing temperature, and the mass ratio of gelatin 
and artesunate on the nanocapsules were investigated.
Materials and methods
Materials
Artesunate powder (98.99%, W/W) was purchased from Wuhan 
Kanglong Pharmaceutical LTD Company, China. Gelatin 
(Mmw = 15000–25000; isoelectric point = 4.9) was chemical 
grade and purchased from Tianjin Tai Lande   Chemical Reagent 
Factory, China. Ethanol alcohol, glacial acetic acid, and formal-
dehyde were reagent grade (Tianjin Kermel Chemical Reagent 
LTD Company, China). All were used as received and without 
any further purification. Well deionized water was used.
Methods
Preparation of nanocapsules by using firstborn 
microcrystallization method
The proposed method included five steps. In the first step, 
2 g of gelatin dissolved in 100 mL of water, the mixture 
was stirred for more than 24 hours at room temperature to 
form gelatin solution, and the impurities removed by using 
vacuum distillation. In the second step, artesunate dissolved 
  sufficiently in hydrophilic organic solvent to saturated 
  solution by stirring continuously. And 10% of acetic acid 
aqueous solution was obtained. In the third step, saturated 
artesunate solution was dropped into 15 mL of gelatin solution 
heating at 40°C at low-speed stirring (about 150 rpm). Next, 
acetic acid solution was added into this mixture to regulate pH 
4.9, and then cooled to room temperature. Finally 0.25 mL of 
formaldehyde, a curing agent, was added slowly at tempera-
ture and stirred continuously for 30 min to cure the walls of 
the capsules. The resulting samples were dialyzed and purified 
by vacuum distillation and then freeze-dried.
Preliminary determination of experimental results
The aim is to explore preparation conditions of the nanocap-
sules by using firstborn microcrystallization method. To save 
time and narrow scopes, Tyndall scattering phenomena and 
phase separation were used to detect the samples.
Morphological analysis
Morphology is a critical factor to analyze final result. In this 
work, the morphology of nanocapsules was observed by a 
TECNAI G2–20 S-Twin-type (Czech Republic) transmission 
electron microscope (TEM) operating at 100 kV .
Results and discussion
Preparation theory
After the saturated artesunate solution was dropped into water 
including enough wall materials, gelatin, the hydrophilic organic 
solvent dissolved immediately in water. Because the solubility 
parameter of hydrophilic organic solvent is less than that of 
water, artesunate crystallizes in time. Once its firstborn crystals 
with nanoscale arose, the wall materials gathered on its surface 
and wrapped gradually the crystals. Finally the wall materials 
deposited on the surface to form a continuous membrane, and 
then form the walls of capsules by adding a curing agent (as 
shown in Figure 2).
Preliminary determination
Tyndall phenomenon is a significant characteristic for col-
loid solution. Because artesunate cannot dissolve in water, 
the solution including the products treated by vacuum have 
Tyndall phenomenon and no phase separation after microen-
capsulating, which means that the solution is colloid solutions 
and the capsules including artesunate must belong to the size 
of colloid. Thus Tyndall phenomenon and phase separation 
may be used as preliminary determination of the samples.
Figures 3A and 3B are Tyndall phenomenon and TEM 
photos, respectively, of the sample when the mass ratio of 
gelatin and artesunate is 5. Tyndall phenomenon is obvious 
and there is no phase separation in Figure 3A. From Figure 3B, 
artesunate was wrapped in higher quality, and the structure of 
the capsules is very clear, and its maximum size is about 76 nm, 
which means it is reliable to prepare the   nanocapsules by using 
firstborn microcrystallization method.
Figure 1 Schematic illustration of artesunate.
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Selection of solvents
In the experiments ethanol alcohol and acetone were chosen 
as solvents. When ethanol alcohol being a solvent, artesu-
nate dissolved well, and there is no precipitating artesunate. 
While acetone being a solvent, some artesunate precipitated 
and was not wrapped completely. Because the solubility 
of artesunate in ethanol alcohol is much higher than that in 
acetone, and acetone is more volatile than ethanol alcohol 
resulting in artesunate precipitating easily when the outside 
temperature is higher. Simultaneously acetone has the toxic-
ity, thus ethanol alcohol was selected as solvent in following 
experiment. In this study, as wall materials of nanocapsules, 
gelatin contains mainly protein, therefore much more ethanol 
alcohol will make gelatin variability and the best artesunate 
ethanol solution is a saturated solution.
Heat during artesunate dissolving
Because the process of artesunate dissolving in ethanol 
  alcohol is slow, heat was used to promote dissolution. 
The results displayed that all products by heating at 40°C have 
precipitation and no Tyndall scattering phenomenon, while the 
results for others not heating is exciting. The   possible reason 
is that the peroxy bond in artesunate reacts with hydroxyls 
resulting from ethanol alcohol when heated.
The mass ratio of gelatin and artesunate
Gelatin is a water-soluble protein and has good film-forming 
characteristics, so it is nontoxic and widely used to prepare 
microcapsules as wall materials. Overdose of gelatin leads 
easily to not only the walls of capsules thickening and the 
monodispersity being not well, but also the nanocapsules 
crosslinking each other and the final products caking. While 
its lowdose results in poor encapsulation, some artemisia crys-
tallizating in water, and affected morphology of the capsules. 
Therefore gelatin dosage is the most influential factor.
In the work, when the mass ratio of gelatin and artesunate 
is less than 1, the resulting solution has phase separation, which 
means the experiment fails. When the mass ratio increased 
from 1, 3 to 5, all products had Tyndall phenomenon, and the 
phenomenon was more obvious, which mean the package of 
the nanocapsules is more complete. Figures 4A 4B are the 
freeze-drying samples and TEM photos of different mass ratio, 
respectively. Figure 1A shows that the dried product is a small 
and white powder when the ratio is equal to 1, while the products 
are coarser and the crosslinking degree increases with increas-
ing the ratio. Figure 1B shows that the diameter becomes larger 
and the crosslinking degree among the nanocapsules increases 
when the ratio increases, which was used to explain the scat-
tering phenomenon is more obvious or the crosslinking degree 
among the nanocapsules with increasing the ratio.
Figure  2  Schematic  illustration  of  the  concept  of  the  proposed  firstborn 
microcrystallization method and the preparation procedure of the nanocapsules.
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Figure 3 Preliminary determination of the nanocapsules. A) Tyndall phenomenon and 
B) TEM photographs.
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Figure 4 The dried samples (A) and TEM photographs (B) of the nanocapsules of 
the mass ratio of gelatin and artesunate being 1 [1], 3 [2] and 5 [3].International Journal of Nanomedicine
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Formaldehyde
Formaldehyde plays the role in curing the walls of the   capsules 
in the study. When gelatin meets formaldehyde at pH 4.9, the 
curing reaction of the capsules happens. Gelatin, the walls 
of the capsules, fall off easily when the temperature is too 
high, so addition of formaldehyde helps to cure the walls. If 
an excessive amount of formaldehyde cannot remove in time 
after the curing experiment is finished, it is easy to form the 
cross-linking gels among the capsules and the gel is not revers-
ible. While formaldehyde is so small that a certain amount 
of the capsules falls and the formation of the capsules is not 
complete. In the work, curing time was kept 30 min, and then 
formaldehyde was removed by using vacuum distillation.
Curing temperature
Control of curing temperature is the key to the success of the 
experiment. In order to explore a temperature range, higher 
than 5°C and 0–5°C were chosen because the mixed solution 
is frozen when the temperature is lower than 0°C. Preliminary 
results are that there has precipitation in the solution for gelatin 
itself being off when the temperature is higher than 5°C. When 
the temperature is from 0–5°C, the results are ideal. Therefore 
0–5°C was selected as curing temperature.
Conclusion
In summary, a novel strategy called firstborn   microcrystallization 
method was developed to explore preparation   conditions of 
the nanocapsules. Effects of some factors such as organic sol-
vent, formaldehyde dosage, artesunate   dissolving and curing 
temperature, and the mass ratio of gelatin and artesunate on 
the nanocapsules were investigated. By using this method, one 
important advantage is that the preparation is easy to operate 
and is a one-time process with no other cumbersome processes, 
therefore avoiding   secondary pollution for the final product. 
The method can be applied to prepare monodisperse nano-
capsules to increase bioavailability of hydrophobic solutes, 
which is highly   attractive for targeting drug delivery systems, 
chemical separations, sensors and so on.
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